Posts

TACT Pivotal Clinical Trial of TULSA-PRO®: All Primary Efficacy and Safety Endpoints, and Key Secondary Endpoints Achieved

April 5, 2019/in News /by ProfoundMarketing

Read more

https://profoundmedical.com/wp-content/uploads/2019/04/Profound_Logo-on-Blue.jpg 675 1200 ProfoundMarketing https://profoundmedical.com/wp-content/uploads/2019/07/RGB_PROFOUND_For-Website-01-01.png ProfoundMarketing2019-04-05 15:42:532019-04-15 16:36:32TACT Pivotal Clinical Trial of TULSA-PRO®: All Primary Efficacy and Safety Endpoints, and Key Secondary Endpoints Achieved